103
Participants
Start Date
September 30, 2016
Primary Completion Date
December 31, 2018
Study Completion Date
December 31, 2022
Daclatasvir and Asunaprevir
Daclatasvir and Asunaprevir combined treatment will not be assigned to the enrolled patients, but the patients who are treated with Daclatasvir and Asunaprevir will be included in this observational study.
Soon Chun Hyang University Bucheon Hospital, Bucheon-si
Korea University Ansan Hospital, Ansan
Gachon University Gil Medical Center, Incheon
Inha University Hospital, Jung-gu
Wonju severance christian hospital, Wŏnju
Soonchunhyang University Cheonan Hospital, Cheonan
Severance hospital, Seoul
Soonchunhyang University Hospital, Seoul
Hanyang university hospital, Seoul
Ewha Womans University Mokdong Hospital, Seoul
Collaborators (1)
Seoul National University Boramae Hospital
OTHER
Severance Hospital
OTHER
Inha University Hospital
OTHER
Korea University
OTHER
Gachon University Gil Medical Center
OTHER
Hanyang University Seoul Hospital
OTHER
Ewha Womans University Mokdong Hospital
OTHER
Bristol-Myers Squibb
INDUSTRY
Sang Gyune Kim
OTHER